10 years of improving asthma management with the NObreath® FeNO monitor
Using FeNO measurements to evaluate airway inflammation in asthma represents a significant advance in respiratory medicine1, but until now it has been an expensive test to deliver in every day practice. Recommended by NICE2 and conformed to ERS/ATS guidelines3, the NObreath® FeNO monitor is the essential tool for asthma.
To celebrate 10 years of the NObreath® improving asthma management, Bedfont® Scientific Ltd. want you to know your FeNO™ and so they are giving you the chance to win a NObreath® FeNO monitor of your own at ERS 2017.
For the chance to win a NObreath® FeNO monitor, simply know your FeNO™:
1. Take a NObreath® FeNO reading
2. Smile for the camera
3. Be entered into the prize draw
4. Like and share on social media using #knowyourFeNO for extra chances to win
To find out more about the NObreath®, please click here.
1. Andrew D. Smith, Jan O. Cowan, Sue Filsell, Chris MacLachlan, Gabrielle Monti-Sheehan, Pamela Jackson and D. Robin Taylor. Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests. Am J Respir Crit Care Med Vol 169. pp 473-478, 2004.
2. Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | Guidance and guidelines | NICE [Internet]. Nice.org.uk. 2014 [cited 11 July 2017]. Available from: https://www.nice.org.uk/guidance/dg12
3. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005; American Journal of Respiratory and Critical Care Medicine; vol. 171: 912-930;2005